Your Liver's Clock Determines How Well It Survives Surgery
A key circadian protein BMAL1 controls liver injury during surgery via autophagy — and timing of the procedure dramatically changes outcomes.
Summary
Researchers discovered that the severity of liver damage during ischemia/reperfusion — a critical concern in liver surgery and transplantation — depends heavily on the time of day. The circadian protein BMAL1, expressed in hepatocytes, directly regulates a lipid droplet protein called HSD17B13. This protein controls autophagy flux, the cellular cleanup process that prevents toxic lipid accumulation. Mice subjected to ischemia/reperfusion at ZT12 (active phase) suffered significantly worse liver injury than those at ZT0 (rest phase). Blocking HSD17B13 worsened injury regardless of timing, while overexpressing a humanized version was protective at ZT0 but harmful at ZT12. The BMAL1/HSD17B13 axis emerges as a promising therapeutic target for improving liver surgery and transplant outcomes.
Detailed Summary
Hepatic ischemia/reperfusion injury (HIRI) is a major complication of liver surgery, transplantation, and trauma, contributing significantly to post-operative morbidity. Despite growing evidence that circadian rhythms influence liver biology, the molecular mechanisms connecting the body's internal clock to HIRI severity have remained largely unknown.
This study, published in the Journal of Hepatology, investigated how the master circadian transcription factor BMAL1 modulates liver injury across different times of day. Using mouse models with hepatocyte-specific or myeloid cell-specific Bmal1 deletion, researchers demonstrated that circadian control of HIRI is driven specifically by hepatocyte BMAL1, not immune cells. Liver injury was significantly worse when ischemia/reperfusion was initiated at ZT12 compared to ZT0 in wild-type mice.
Mechanistically, BMAL1 was found to directly bind E-box-like elements in the promoter of Hsd17b13, a gene encoding a lipid droplet-associated protein. This binding drives diurnal oscillation in HSD17B13 expression. When HSD17B13 was depleted, autophagy flux was blocked, causing lipid overaccumulation and exacerbating liver injury. Conversely, hepatocyte-specific overexpression of humanized HSD17B13 conferred protection at ZT0 but paradoxically worsened damage at ZT12, underscoring the complexity of time-dependent biological responses.
The study's clinical implications are substantial. Surgical timing relative to circadian phase may be an underappreciated variable in outcomes for liver transplantation and resection. Targeting the BMAL1/HSD17B13 axis pharmacologically could offer new strategies for protecting the liver regardless of procedural timing.
Important caveats include that this research was conducted entirely in mouse models, and translation to human surgery requires clinical validation. The paradoxical effect of HSD17B13 overexpression at ZT12 also warrants further mechanistic investigation before therapeutic application.
Key Findings
- Liver injury was significantly worse at ZT12 versus ZT0, confirming strong circadian gating of HIRI severity.
- Hepatocyte BMAL1, not myeloid BMAL1, is the primary driver of time-of-day differences in liver injury.
- BMAL1 directly transcribes HSD17B13 via E-box elements, linking the circadian clock to lipid droplet biology.
- Loss of HSD17B13 blocks autophagy flux, causing lipid overload and worsening HIRI at both timepoints.
- Humanized HSD17B13 overexpression was protective at ZT0 but aggravated injury at ZT12.
Methodology
The study used hepatocyte-specific and myeloid cell-specific Bmal1 knockout mice, alongside global and hepatocyte-specific HSD17B13 knockout, knockdown, and humanized overexpression models. Ischemia/reperfusion was performed at ZT0 and ZT12 to capture circadian variation. RNA sequencing and molecular techniques were used to identify the BMAL1–HSD17B13 transcriptional axis and its effects on autophagy.
Study Limitations
All experiments were conducted in mouse models; human circadian physiology and HSD17B13 function may differ importantly. The protective versus harmful dual role of HSD17B13 depending on circadian phase adds complexity that must be resolved before clinical translation. The abstract does not detail how human shift work or circadian disruption might interact with these findings.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.